Sexually Transmitted Human Papillomavirus: Update in Epidemiology, Prevention, and Management.
Plotzker RE, Vaidya A, Pokharel U, Stier EA.
Infect Dis Clin North Am. 2023 Jun;37(2):289-310. doi: 10.1016/j.idc.2023.02.008.
Human papillomavirus and cervical cancer.
Crosbie EJ, Einstein MH, Franceschi S, Kitchener HC.
Lancet. 2013 Sep 7;382(9895):889-99. doi: 10.1016/S0140-6736(13)60022-7. Epub 2013 Apr 23.
Prevention and treatment of human papillomavirus in men benefits both men and women.
Zou K, Huang Y, Li Z.
Front Cell Infect Microbiol. 2022 Nov 24;12:1077651. doi: 10.3389/fcimb.2022.1077651. eCollection 2022.
Causal attribution of human papillomavirus genotypes to invasive cervical cancer worldwide: a systematic analysis of the global literature.
Wei F, Georges D, Man I, Baussano I, Clifford GM.
Lancet. 2024 Aug 3;404(10451):435-444. doi: 10.1016/S0140-6736(24)01097-3.
Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial.
Winer RL, Lin J, Anderson ML, Tiro JA, Green BB, Gao H, Meenan RT, Hansen K, Sparks A, Buist DSM.
JAMA. 2023 Nov 28;330(20):1971-1981. doi: 10.1001/jama.2023.21471.
Canadian Guideline on the Management of a Positive Human Papillomavirus Test and Guidance for Specific Populations.
Zigras T, Mayrand MH, Bouchard C, Salvador S, Eiriksson L, Almadin C, Kean S, Dean E, Malhotra U, Todd N, Fontaine D, Bentley J.
Curr Oncol. 2023 Jun 9;30(6):5652-5679. doi: 10.3390/curroncol30060425.
Quadrivalent vaccine against human papillomavirus to prevent high-grade cervical lesions.
FUTURE II Study Group.
N Engl J Med. 2007 May 10;356(19):1915-27. doi: 10.1056/NEJMoa061741.
Human Papillomavirus among Women Undergoing Papanicolaou Smear Test in the Department of Gynaecologic Oncology of a Tertiary Care Centre.
Shrestha MR, Basnet A, Maharjan R, Ghimire S, Khatri N, Shrestha A, Karki L, Karmacharya S.
JNMA J Nepal Med Assoc. 2023 Dec 1;61(268):931-933. doi: 10.31729/jnma.8363.
Distribution of human papillomavirus prevalence, genotype, and PAP test results in women in the southeast of Turkey.
Aydogdu G.
Cir Cir. 2023;91(3):319-325. doi: 10.24875/CIRU.22000400.
Head-to-head immunogenicity comparison of an Escherichia coli-produced 9-valent human papillomavirus vaccine and Gardasil 9 in women aged 18-26 years in China: a randomised blinded clinical trial.
Zhu FC, Zhong GH, Huang WJ, Chu K, Zhang L, Bi ZF, Zhu KX, Chen Q, Zheng TQ, Zhang ML, Liu S, Xu JB, Pan HX, Sun G, Zheng FZ, Zhang QF, Yi XM, Zhuang SJ, Huang SJ, Pan HR, Su YY, Wu T, Zhang J, Xia NS.
Lancet Infect Dis. 2023 Nov;23(11):1313-1322. doi: 10.1016/S1473-3099(23)00275-X. Epub 2023 Jul 17.
